Search This Blog

Sunday, January 20, 2019

Pretend Your Time is Worth $1,000/Hour and You’ll Become 100x More Productive


“Pretend your time is worth $1,000/hr. Would you spend five of them doing extra work for free? Would you waste one on being angry?” –Niklas Göke
You have very few hours here on on this earth.
Still, many people waste much of their time on pointless, low-quality activities that don’t help them reach their true goals — their mission.
The truth is, most people value their time at far, far less than it’s worth.
They say yes to things they have no business doing. They give away their talents, attention, and effort to others who take, take, take.
They spend hours watching low-quality television and social media when they should be productive and effective.
See, many people could be making a fortune (if they used their time well)…but instead, they give away their time in unproductive ways that leave them broke, unhappy, and stuck.
But what if you placed a high value on your time?
How would that change you? Your life? Your family? Your future?
Imagine that an hour of your time is worth $1,000.
What would your life look like?
What people would you stop putting up with?
What problems would you stop wasting time on?
What things would you stop — and start — doing?
Your results would be incredible. You’d become exponentially more productive, focused, and effective.
“Most people have no clue what they are doing with their time but still complain that they don’t have enough.” -Grant Cardone, NYT best-selling author

“Busyness” Isn’t a Badge of Honor; It’s a Sign of Weakness

“Being busy is a form of mental laziness.” -Tim Ferriss
It takes discipline to not become “busy.”
If you let it, your world and the people around you will take all your time. Your time is not unlike your paycheck; if you don’t budget for things, you’ll have nothing left over by the end of the month.
This is how lives are wasted — by doing thankless work for ungrateful takers that didn’t deserve your time in the first place.
We’re all busy — with work, our families, our friends. It’s not bad to be “busy.” But in the words of best-selling author Jeff Goins:
The most successful people I know are not busy. They’re focused.
Are you focused, making tangible action steps towards what truly matters?
…Or are you just “busy?”
When you’re busy, you are on autopilot. You can’t see the hours slipping away, time you’ll never get back. When you’re preoccupied, you’re
Wrote the ancient philosopher Seneca:
“Indeed the state of all who are preoccupied is wretched, but the most wretched are those who are toiling not even at their own preoccupations…If such people want to know how short their lives are, let them reflect how small a portion is their own.”
Who’s in charge of your time?
You?
Or everyone else?

Busyness and Stress Are the Enemy

“People are unhappy in large part because they are confused about what is valuable.” -William Irvine
Most people prize “being busy.” They proclaim it with pride, as if it’s a badge of honor.
But for most people, this “busyness” is nothing more than distraction and procrastination from what really matters. They just like feeling busy.
Said author Benjamin Hardy, “Most people lack the confidence to go big. They prefer the dopamine boost of getting lots done, even if they aren’t making any progress.
For world-class performers, busyness and stress are the enemy. They’re a sign you’re off-track. It means you’ve been lazy and undisciplined, and have let too many unimportant tasks take you away from what really matters.
“Being busy is a form of mental laziness.” -Tim Ferriss
Bestselling author Jeff Goins once wrote, “The most successful people I know are not busy. They’re focused.” Extremely successful people don’t tolerate busywork or distraction. They have crystal clear vision on their goals, and do what they need to do to get there, every single day.
In his landmark book Deep Work, Cal Newport recounts some choice insights on how to develop insanely productive results through removing all distraction and entering flow states:
“Busyness and exhaustion should be your enemy. If you’re chronically stressed and up late working, you’re doing something wrong. Do less. But do what you do with complete, hard focus. Then when you’re done be done, and go enjoy the rest of your day.”
Deep work means absolutely not tolerating distractions and producing monumental quality and quantity in a very short time. This is how you can complete far more with focused efforts than unfocused efforts with far more time.
Do you want incredible productivity?
Then cultivate extreme focus with whatever you do.
If you don’t manage your time, it will manage you.
“When you have less time available for work, you have to make better choices about what to work on (and what not to).” -Tim Metz

As You Think, So You Are

“As a man thinketh, so is he. As he continues to think, so he remains.” -James Allen
You teach people how to treat you.
If you let people know your time is free and low-valued, people will treat it as such.
But if you teach people that your time is expensive, important, and valuable, then people will respond in kind.
What you think is what you become. If you think your time is worth a few bucks an hour, that you’ll begin to act like it. You’ll find yourself saying “yes” to meaningless, pointless obligations.
But if, in your heart, you know your time is valuable…
People will recognize that.
People will respect that.
People will treat you differently.
Wrote author William Irvine:
“People are unhappy in large part because they are confused about what is valuable.”
If you don’t treat yourself and your time with respect, you will become unhappy, resentful, and tired. Your body and mind long for mastery and freedom; you can’t have those things if your time is cheap and easily taken.
You become what you are.
You attract what you look for.
Back in my early days of writing, I didn’t think I was much of a writer. So I spent a lot of time on low-quality activities, like begging other low-tier/no-name bloggers to let me write guest posts.
No one responded to me. I rarely was invited to write. I think people could see how little I valued myself, and didn’t want to promote my message. I don’t even blame them.
Years later, I finally began seeing my time as very important. I began saying “no” to almost everything. I had a mission, and I became unwilling to fill my valuable time with things that wouldn’t help me achieve my goal.
I turned down high-paying, exciting, interesting opportunities…because they weren’t the right fit. In the end, they were all wasting time I needed to focus on my mission.
As you think, so you are.
Treat your time as a valuable commodity, and people will begin to treat it like that, too.

You Can Do Amazing Things, But Only If You Have Time to Do Them

“The difference between successful people and really successful people is that really successful people say no to almost everything.” -Warren Buffet
You probably need to say “no” more.
Every time you say yes to something, it means you’re saying “no” to a dozen other opportunities. The world’s most successful and extraordinary people say no to almost everything, but yes to a few things.
Those few things determine their career, legacy, and livelihood.
Warren Buffet, investor extraordinaire and a net worth of over $70 billion dollars, has said that for every hundred opportunities he is given, he might say yes to 1–2 of them.
Really successful people say no to most things, because most things won’t get them to where they truly want to be.
Steve Jobs also shared this mentality. Decades ago, Jobs was quoted:
“People think focus means saying yes to the thing you’ve got to focus on. But that’s not what it means at all. It means saying no to the hundred other good ideas that there are. You have to pick carefully. I’m actually as proud of the things we haven’t done as the things I have done. Innovation is saying no to 1,000 things.”
This process of weeding out the merely “good” for the truly great opportunities is easier when you value your time at $1,000/hour. Anything you can honestly justify doing for $1,000/hour is probably a good thing.

In Conclusion

“Living in frenzy is a sign we’ve squandered too much.” -Niklas Goke
In reality, a lot of people are living a frenzied, busy life. They wear their business as a badge of honor, and brag about their full schedules.
Frankly, most people prefer the little dopamine boost of checking boxes on a to-do list than actually getting important work done.
How do you value your time?
Take stock of the things you did this week. How many of them were worthy of $1,000/hour?
How many activities were a true waste of time?
Value your time at what it deserves to be. The higher the value, the more important and productive work you’ll do — and the less trivial and mindless tasks you’ll get caught in.

Putting in the Reps


One of the best parts of the on-demand entertainment world we now live in is that you can consume content from people in different formats than you could in the past.
When I was in high school and college Late Night with Conan O’Brien show was appointment viewing for me and my friends. His first episode was in 1993 (which makes me feel really old) and I was in from the start. Conan was the perfect show to watch late-night after a few beers with friends because it was hilarious, a little weird, and had some amazing moments with celebrities who would let their guard down for him.1
It’s been years since I’ve watched Conan because I’m too busy waking up at 2:30 am but I was excited to learn about the release of his new podcast, Conan O’Brien Needs a Friend. It felt like I was reconnecting with an old friend from a bygone era of my life.
The guest line-up so far has been stacked: Will Ferrell, Kristen Bell, Dax Shepard, Nick Offerman, Megan Mullally, and Marc Maron, to name a few.
But the latest episode with Adam Sandler was spectacular.
They touched on their time together at SNL in the 1990s during the Chris Farley era (which is bar none the greatest SNL run in history). O’Brien was a writer on the show before Sandler joined as a cast member and mentioned how surprising it was for a new cast member to come in with such bravado and confidence right off the bat.
He asked Sandler what that confidence stemmed from. Sandler said he told all of his friends back home how huge he was going to be, so it was more or less a show to prove to himself that he belonged even though he was still a young up and comer in the industry.
Conan said he saw some similarities between how Sandler and Eddie Murphy handled themselves early on in their career.
Conan related a story he heard from another stand-up comedian about Murphy’s early days on stage. Eddie was 17 or 18 years old and trying to make it on the stand-up circuit. One night at a club there was a group of comedians getting ready to perform backstage when they realized no one showed up for the show. Beyond the wait and bar staff, there may have been one or two people in the crowd.
All of the other comedians were angry and left. Murphy didn’t care. He still went on stage and did his whole set for basically nobody. He knew he had to put in the work so he wanted to get in the reps in regardless of the size of the audience.
Murphy, of course, went on to become one of the biggest stand-up acts in the world and after cutting that part of his career short, one of the biggest movie stars in Hollywood.2
I’m sure he had no idea how famous he would become when he was just starting out but he obviously took himself seriously enough to put in the reps to hone his craft, even when it wouldn’t lead to an immediate payoff.
I get a lot of questions from people about how to break into certain business lines in finance at a young age or during a career transition.
There’s no singular path to success in any endeavor so my advice to anyone looking to further themselves is to put in the reps, even when they seem meaningless.
If you want to become a writer, start writing every single day, even if it’s terrible.
If you want to become a better investor, start reading about the markets, and put some actual money to work.
If you want to work in a specific company, start out as an unpaid intern or figure out how to provide value to someone who already works there.
If you want to become an entrepreneur, quit reading hashtags on Instagram and actually try to start a business or sell a product.
If you want to become something or someone you have to put in the reps.
There are no shortcuts.

‘It Pays to be Vertical,’ Curaleaf CEO Tells Cannabis Capital Conference


The topic on everyone’s minds at Benzinga’s Cannabis Capital Conference Wednesday in Miami Beach was how to maintain an edge and maximize profits as a market still in its infancy faces explosive growth amid political uncertainty.
On hand to offer his expertise was Curaleaf Holdings Inc CURLF 1.69% CEO Joseph Lusardi, arguably one of the largest multistate operators in the space — the company holds licenses in 11 states. During a fireside chat moderated by 420 Investor Alan Brochstein, Lusardi told the crowd: “It pays be to be vertical.”

Execution Is Key

The cannabis industry veteran, who joined Curaleaf in 2016, has led the firm to massive growth: in 2018 they opened more dispensaries in Florida than any other company and have set their sights on nationwide expansion through their line of hemp products. The key to success during this integral time for the cannabis industry lies in execution in order to create a consistent consumer experience across the board, Lusardi said.
Despite the fact that Curaleaf has a presence in multiple markets, the company chose to stick with one cohesive brand under the company name at a time when many brands are laser-focused on the desires of customers in varying markets. This commitment to perfecting the Curaleaf name has been critical to the company’s success, the CEO said, going on to offer insight on how to further increase the number of SKUs under one line.
“Bioavailability is going to become more important in order to differentiate products and effects and meet the needs of a broader consumer base,” he said, adding that precision dosing and lesser-known cannabinoids are also topics of discussion in terms of the future of the industry.

The Industry’s Biggest Threat

When asked who or what the biggest threat to the American cannabis industry is, Lusardi’s answer was not “Canada,” despite the fact that it’s the first developed nation to legalize marijuana. It’s the black market, he said.
“The market is valued at $50 billion, but only $10 billion of that comes from legal sales,” the CEO said, noting that broader reform of cannabis laws could help ease high prices currently seen in many legal markets — one of the main drivers of the so-called black market.

Positive Prognosis For Health Care ETFs


Health care, the second-largest sector weight in the S&P 500 behind technology, was one of just three sectors to post positive returns last year. As measured by the Health Care Select Sector SPDR XLV 1.13%, the largest exchange traded fund dedicated to health care stocks, the sector is off to an impressive start in 2019; XLV is up nearly 3 percent this year.

What Happened

XLV and rival health care ETFs proved resilient last year as growth and momentum sectors fell out of favor with investors. The fund gained 6.3 percent last year while its technology counterpart lost 1.7 percent. While health care is widely viewed as a defensive sector, its 2019 earnings growth is expected to be solid.
“While analysts have downgraded S&P 500® Index earnings for 2019, earnings growth in the Heath Care sector remains intact on the back of stable demand and strong product pipeline,” said State Street in a note out last Friday.

Why It’s Important

XLV targets the Health Care Select Sector Index, providing “exposure to companies in the pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and health care technology industries,” according to the issuer.
Pharmaceuticals and biotechnology stocks combine for about half of XLV’s roster. Some comparisons confirm XLV’s defensive posture. While the ETF has been slightly more volatile than the S&P 500 over the past three years, XLV was less volatile than its real estate and utilities counterparts over that span. Plus, health care has a consistent stream of potential catalysts, a trait not found across all sectors.
“In 2018, the FDA approved 59 novel drugs, exceeding last year’s record for the second consecutive year,” said State Street. “A record number of FDA novel drug approvals over the past two years is likely to fuel sales for new drugs in coming years. In addition, with an aging population driving demand for more medical services and products, US national health spending is projected to grow at a faster rate than normal GDP growth between 2017 and 2026 and more rapidly than the 2008–2016 period, benefiting the sector on a broad basis.”
What’s Next
Identifying what’s next for XLV is easy: earnings. Over the next two weeks, about two-thirds of the components in XLV’s underlying index report quarterly results. Investors have added $153.42 million to XLV this year.

An extra meal a day cuts deaths by half in elderly with hip fractures


A pilot scheme called the HIP QIP programme was implemented across six trusts. Five of these were in England and one in Scotland. The scheme involves giving the elderly patients with hip fractures one extra meal per day. Results showed that this strategy can reduce the deaths among these patients by half.
The pilot scheme was led by the Northumbria Healthcare NHS Foundation Trust. Health care staff there first noted that elderly patients admitted with hip fractures seemed to be deficient in nutrients and also failed to consume adequate nutrients from food. The HIP QIP programme allowed these patients one extra meal a day. The scheme started two years back. The nutrition advisors provided these elderly hip fracture patients with one extra meal a day from the shops and hospital canteens and sat with them while the patients ate. The scheme was found to be successful and future applications of this strategy is on the cards.
According to experts, the extra meal provided to geriatric wards under the HIP QIP programme provided extra calories and also improved the morale of the patients that helped them recover faster. The mortality or death rates from hip fractures among the elderly dropped from 11 percent to 5.5 percent in the initial pilot trial. This pilot trial was launched in 2016 and it was noted that an extra meal could also reduce the hospital stay of these patients from an average of 25 days to 20 days.
The Health Foundation states that nearly 65,000 patients were admitted with hip fractures in 2015 and of these around one third succumb within one year of the fracture. Around 4,000 elderly people die within a month of their hip fractures yearly say the statistics.
Mr Dominic Inman is the chief orthopaedic surgeon for the National Hip Fracture Database. He explained that food intake was not taken into consideration before. He said in a statement, “At that point it’s all about getting calories into the patient. If you look upon food as a very, very cheap drug, that’s extremely powerful.”

Immune checkpoint inhibitors induce rheumatic and musculoskeletal diseases


Checkpoint inhibitor therapy is a form of cancer treatment immunotherapy currently under research. The therapy targets immune checkpoints, key regulators of the immune system that stimulate or inhibit its actions, which tumors can use to protect themselves from attacks by the immune system. As Immune checkpoint inhibitors are happened to be new antitumor drugs and they are related to immune-related Adverse Events (AEs), this includes rheumatic disease and musculoskeletal disease.
In this study, the Medline reports were searched on musculoskeletal and rheumatic AEs which were caused by immune checkpoint inhibitors. Immune checkpoint inhibitors treatments are reported by the studies which are associated with several musculoskeletal and rheumatic AEs in the literature. Whereas, it is reported in case studies and case reports that, arthralgia and myalgia happened to be the most commonly reported AEs although the commonality of arthritis, myositis and vasculitis is pretty much less characterized. AEs which are described later are, sicca syndrome, polymyalgia rheumatica, systemic lupus erythematosus and sarcoidosis.
A frequently adverted event that associates newly induced musculoskeletal and rheumatic diseases with immune checkpoint inhibitors treatment are brought to the surface by new researches.

Breast cancer more likely to metastasize in young women 10 years post childbirth


A study by researchers at University of Colorado Cancer Center and Oregon Health & Science University published today in the Journal of the American Medical Association Network shows that breast cancers diagnosed in young women within 10 years of giving birth are more likely to metastasize, and thus more likely to cause death, than breast cancers in young women who gave birth less recently or not at all.
“This is the first study to demonstrate that a postpartum breast cancer diagnosed up to ten years after last childbirth can independently increase a woman’s risk for developing metastasis to other parts of the body,” says Virginia Borges, MD, MMSc, director of the Breast Cancer Research Program and Young Women’s Breast Cancer Translational Program at CU Cancer Center.
Borges is co-senior author on the study with longtime collaborator, Pepper Schedin, PhD at OHSU. One of the co-first authors, Erica Goddard, PhD, began her doctoral work at CU Cancer Center and completed it at OHSU in the lab of Schedin, co-mentored by Borges. Dr. Goddard is now a postdoctoral researcher at Fred Hutchinson Cancer Research Center.
The team analyzed the data of 701 female breast cancer patients, ages 45 and below, included in the Colorado Young Women’s Breast Cancer Cohort. Researchers compared the risk for developing distant metastases among three groups: Women who had never had a child; women who had their last childbirth within the past 10 years; and women with children born more than ten years prior to their diagnosis. This risk for developing metastases in these groups was also evaluated across well-known breast cancer risk features.
The increased risk for metastasis was highest in the women up to ten years postpartum and was most pronounced in women with stage I or II breast cancer, with a 3.5-to-5 times higher risk than women with similar, non-pregnancy associated cancers. For estrogen-receptor positive tumors, increased risk of metastasis was present up to 15 years post-diagnosis, approaching the level of metastasis risk associated with dangerous forms of breast cancer including ER-negative and triple-negative breast cancers.
“In these cancers, the tumors themselves do not appear different – there’s no difference in the percent that are more aggressive subtypes, such as triple-negative or Her 2, no difference in the stage at which they are diagnosed, or other differences in classic measures that you might think would increase the chance of a bad prognosis,” Borges says. “Instead, these data support previous findings from our team’s lab work showing that after childbirth, conditions in surrounding breast tissue may aid the development of metastases. For example, we have shown that the laying down of new lymph channels in breast tissue after childbirth and nursing may allow cancer cells to better travel and seed sites of metastasis; sure enough, the current work finds more women having cancer in their lymph nodes at diagnosis.”
According to the National Cancer Institute, every year 25,000 women below the age of 45 are diagnosed with breast cancer in the United States. Data from the current study suggest that about 45 percent of these cancers occur within 10 years of childbirth, meaning that annually just over 11,000 American women are at increased risk of metastasis from postpartum breast cancer.
“These findings highlight the need to understand that postpartum breast cancer may represent a unique subtype of cancer that requires distinct care. All women know when they last gave birth, so this is a readily available, free piece of information that helps us identify young women at highest risk from their breast cancer,” Borges says. “If we are aware of the increased risk, we can work towards finding the best means to overcome this risk and treat it appropriately.”